Home | Welcome to Contract Pharma   
Last Updated Wednesday, May 22 2013
Print

Industry News

Related Searches:

Filter by:

May 7, 2010
Meda has acquired exclusive rights to flupirtine for the treatment of fibromyalgia from Adeona Pharmaceuticals, in the U.S., Canada and Japan.   Read More »
May 5, 2010
PPD, Inc. has opened a pharmacovigilance and medical communications center in Sofia, Bulgaria, to provide a full range of drug safety, medical information and medical writing services.   Read More »
May 3, 2010
Althea Technologies, Inc. has acquired the assets and portfolio of Altus Pharmaceuticals.   Read More »
May 3, 2010
DSM Biologics has entered an agreement to partner with the Australian Governments (Queensland State Government and the Commonwealth of Australia) to design, build and operate a mammalian biopharmaceutical manufacturing facility in Brisbane.   Read More »
April 28, 2010
Norwich Pharmaceuticals, Inc. has formed Norwich Clinical Services to provide clinical testing capabilities to expand the company’s third party services.   Read More »
April 27, 2010
New research site expands ability in oral solid formulations   Read More »
April 26, 2010
Charles River Laboratories will acquire WuXi PharmaTech for approximately $1.6 billion.   Read More »
April 26, 2010
Cytovance Biologics and Selexys Pharmaceutical have entered an agreement for the execution of a biopharmaceutical development and manufacturing collaboration for Anti-PSGL-1, a monoclonal antibody (mAb) being developed for treatment of inflammation associ   Read More »
April 22, 2010
Makes second Brazil acquisition this year.   Read More »
April 19, 2010
Sandoz has signed a definitive agreement to acquire Oriel Therapeutics, a privately held U.S. pharmaceutical company that develops respiratory products as generic alternatives to drugs for asthma and chronic obstructive pulmonary disease (COPD).   Read More »
April 19, 2010
PRA International has established operations in New Zealand, adding to the company’s Asia-Pacific operations.   Read More »
April 15, 2010
Novartis plans to restructure its U.S. operations. According to a company email, sent to employees by David Epstein, head of Novartis Pharmaceuticals, the restructuring is in response to a changing environment and is an effort to innovate the company&   Read More »
April 15, 2010
Charles River Laboratories' Shanghai facility has received a Certificate of Good Laboratory Practice (GLP) compliance from the Organization for Economic Cooperation and Development (OECD).   Read More »
April 13, 2010
Patheon is adding development and manufacturing softgel capability at its Cincinnati facility.   Read More »
April 12, 2010
Javelin Pharmaceuticals, a specialty pharma in the pain management sphere, has received an acquisition bid from Discus, a subsidiary of Hospira, leading Javelin to cancel its previous merger agreement with Myriad Pharmaceuticals.   Read More »
Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On